『The Biorevolution Podcast』のカバーアート

The Biorevolution Podcast

The Biorevolution Podcast

著者： Louise von Stechow
無料で聴く

このコンテンツについて

 The Biorevolution Podcast with Andreas Horchler and Louise von Stechow – father and daughter, journalist and biologist, talking about the technologies of the biorevolution. Can genetic engineering, synthetic biology, and artificial intelligence save humanity from disease, climate change, and overpopulation, or are these technologies the first step towards its downfall? Content and Editing: Louise von Stechow and Andreas Horchler Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics but do not claim to give medical, investment, or life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Image: Kelly Sikkema via Unsplash 博物学 生物科学 科学 自然・生態学
エピソード
  • The biorevolution podcast #35

    The biorevolution podcast #35
    2025/06/02
    Despite great hopes for Artificial Intelligence (AI) in biotech and pharma—with investments exceeding $50 billion over the past ten years—the question of when the technology will reach maturity remains difficult to answer. How can biotech and pharma leaders navigate this complex gray area, where hype around the technology obscures the outlook and few concrete milestones provide clear signposts for decision-making? In this episode of the BioRevolution podcast, Louise von Stechow and Andreas Horchler speak with their guest, idalab founder Paul von Bünau, about the potential of AI in biotech. They explore how leaders can adapt internal processes, support their teams in facing the challenges AI brings, and examine whether AI has the potential to make us better leaders. Find Dr. Paul von Bünau here: https://www.linkedin.com/in/paulvonbuenau/ and idalab here: https://idalab.de/ Disclaimer: Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow Image: Matteo Vistocco via Unsplash
    続きを読む 一部表示
    41 分
  • The biorevolution podcast #34

    The biorevolution podcast #34
    2025/05/05
    More than 20 years after the Human Genome Project, enabled by new sequencing technologies, researchers are making progress in exploring the vast non-coding space that constitutes 98% of our genomes. This non-coding, or "dark," DNA harbors elements with important regulatory functions in health and disease. But pinpointing disease-relevant DNA elements within this massive DNA space can be like searching for a needle in a haystack. This difficult search can be eased by artificial intelligence (AI)-based tools, which predict the context-dependent relevance of certain DNA elements and highlight their role in different diseases, from cancer to rare neurodegenerative disorders. For Episode 33 of the BioRevolution podcast, Andreas Horchler and Louise von Stechow are joined by CTO and co-founder of Berlin-based biotech LUCID Genomics, Dr. Hossein Moeinzadeh, to discuss the exciting field of non-coding DNA and how LUCID’s AI algorithm can help make sense of non-coding DNA — and how this could improve diagnoses of rare diseases and beyond. Learn more about LUCID genomics AI tool here: https://www.lucid-genomics.com/technology Find Dr. Hossein Moeinzadeh here: https://www.linkedin.com/in/mhossein-moeinzadeh/ Disclaimer: Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow Image: via Unsplash.
    続きを読む 一部表示
    38 分
  • The biorevolution podcast #33

    The biorevolution podcast #33
    2025/04/01
    When the Swiss chemist synthesized and tested the psychedelic compound LSD in the 1930s, he knew he had found a tool to explore the human mind. Indeed, before psychedelics became illegal in the late 1960s, a mountain of evidence had been produced, showing potential benefits of psychedelic-assisted therapy for depression, anxiety, and substance abuse. After a decades-long hiatus, research on psychedelics as a treatment for psychiatric diseases is experiencing a renaissance—and initial results look promising. While the field has seen a setback with the recent request for more data by the FDA for the approval of MDMA for PTSD, research into different psychedelic compounds continues, promising new hopes to battle worldwide mental health crises. In the newest episode of the BioRevolution podcast, Andreas Horchler and Louise von Stechow discuss the history, the promise, and the risks of psychedelics as treatments for psychiatric diseases with neuroscientist, psychedelics expert, and executive coach Galyna Pidpruzhnykova https://www.linkedin.com/in/galynapidpruzhnykova/ https://www.galynapipdpruzhnykova.com/ Galyna also outlines her efforts to develop a psychedelics strategy to battle the mental health crisis in Ukraine, where the Ministry of Health published a draft law for research on psychedelic compounds just a few days after we recorded this podcast. https://www.linkedin.com/feed/update/urn:li:activity:7308180815761330176/ Disclaimer: Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
    続きを読む 一部表示
    42 分

The Biorevolution Podcastに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。